Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Danielle Salha"'
Autor:
Marin Ming, Judy Caterini, Luciano Ettorre, Mei Tang, Martha Schreiber, Danielle Salha, Lucy Gisonni-Lex
Publikováno v:
Biologicals. 80:53
Autor:
Danielle Salha, Marin Ming, Nidhi Kapoor, Kimberley Williams, Pappachan E. Kolattukudy, Beata Gajewska, Lidice Bernardo, Fabienne Piras, Leslie G. Chan, Anke Pagnon, Jin Su, Lucy Gisonni-Lex
Publikováno v:
Vaccine. 37:2960-2966
Potency assays for vaccine products are an important regulatory requirement, and are used to assess product quality and consistency prior to lot release for clinical testing. Ideally they measure an established correlate of efficacy or protection. In
Autor:
Daniela Damjanovic, Julie Symes, Luciano Ettorre, Liwei He, Ali Azizi, Sanjay Phogat, Jin Su, Lucy Gisonni-Lex, Beata Gajewska, Lidice Bernardo-Reyes, Danielle Salha
Publikováno v:
Vaccine. 36(37)
The first evidence in humans that a safe and effective preventive vaccine for HIV is possible came from the phase III HIV clinical trial RV144 in Thailand. This trial was based on a prime/boost combination of a recombinant canarypox vaccine and two g
Autor:
Robert Hopfer, Jason Szeto, Karen Ogilvie, Carol L. Claus, Germie P. J. M. van den Dobbelsteen, Marin Ming, Scott Gallichan, Danielle Salha, Mei Tang, Belma Ljutic, David Hanwell, Lisa E. Myers, Benjamin Messham, Martina Ochs, Anthony Sheung
Publikováno v:
Infection and Immunity. 80:2212-2220
Streptococcus pneumoniae pneumolysin (PLY) is a virulence factor that causes toxic effects contributing to pneumococcal pneumonia. To date, deriving a PLY candidate vaccine with the appropriate detoxification and immune profile has been challenging.
Autor:
Thorsten U. Vogel, Ray Oomen, Danielle Salha, Neil L. Berinstein, Corey Lovitt, Tao Wen, Mark Parrington, Linong Zhang, Mei Tang, Lucian Visan, Bryan McNeil, Bill Bradley, Judy Caterini, Devender Sandhu, Belma Ljutic, Nancy Scollard, Shi-Xian Cao, Liwei He, Pamela Dunn, Jim Tartaglia, Beata Gajewska
Publikováno v:
Journal of Immunotherapy. 33:743-758
New therapies are urgently required for the treatment of patients with melanoma. Here we describe the generation and preclinical evaluation of 3 new recombinant ALVAC(2) poxviruses vCP2264, vCP2291, and vCP2292 for their ability to induce the desired
Publikováno v:
Journal of Immunological Methods. 304:43-59
We describe a highly sensitive flow cytometry-based CTL assay using the cleavage of caspase 3 in target cells as a readout. The assay involved labeling of cells with a cell tracker dye and staining permeabilized cells with an antibody recognizing cle